Simone Incicco

Assistan Professor

University of Padova
Country flagItaly

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (15)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Background and Aims: Removal/suppression of the primary etiological factor reduces the risk of decompensation and mortality in compensated cirrhosis. However, in decompensated cirrhosis, the impact of etiologic treatment is less predictable. We aimed to evaluate the impact of etiological treatment in patients with cirrhosis who developed ascites as single index decompensating event. Approach and Results: Patients with cirrhosis and ascites as single first decompensation event were included and followed until death, liver transplantation, or Q3/2021. The etiology was considered “cured” (alcohol abstinence, hepatitis C cure, and hepatitis B suppression) versus “controlled” (partial removal of etiologic factors) versus “uncontrolled.” A total of 622 patients were included in the study. Etiology was “cured” in 146 patients (24%), “controlled” in 170 (27%), and “uncontrolled” in 306 (49%). During follow-up, 350 patients (56%) developed further decompensation. In multivariable analysis (adjusted for age, sex, varices, etiology, Child-Pugh class, creatinine, sodium, and era of decompensation), etiological cure was independently associated with a lower risk of further decompensation (HR: 0.46; p = 0.001). During follow-up, 250 patients (40.2%) died, while 104 (16.7%) underwent LT. In multivariable analysis, etiological cure was independently associated with a lower mortality risk (HR: 0.35, p < 0.001). Conclusions: In patients with cirrhosis and ascites as single first decompensating event, the cure of liver disease etiology represents a main treatment goal since this translates into considerably lower risks of further decompensation and mortality.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (23)

Salvatore Piano

University of Padova

ITALY
View details

Samir Kumar-Singh

Professor of Molecular Pathology

University of Antwerp

BELGIUM
View details

Stine Johansen

Medical doctor

Odense University Hospital

DENMARK
View details

Guillem Pera

Statistician

Escola Superior de Ciències de la Salut TecnoCampus

SPAIN
View details

Mads Israelsen

Rigshospitalet

DENMARK
View details

Aleksander Krag

University of Southern Denmark

DENMARK
View details

Harry de Koning

Full professor

Erasmus University Rotterdam

NETHERLANDS
View details

Carmen Expósito

Profesora asociada

Universitat Autònoma de Barcelona (UAB)

SPAIN
View details

Maja Thiele

Odense University Hospital

DENMARK
View details

Judit Pich

Head of the Clinical Trials Unit

Hospital Clínic de Barcelona

SPAIN
View details

Kavish R. Patidar

Houston Methodist

UNITED STATES
View details

Carmine Gambino

Assistant Professor of Medicine

Azienda Ospedale Università Padova

ITALY
View details

Cristina Laserna Jiménez

Lecturer

University of Barcelona

SPAIN
View details

Mar Coll Loperena

Tenured Associate Professor

University of Barcelona

SPAIN
View details

Marta Carol

Professora Lectora

University of Barcelona

SPAIN
View details

Rafael Bañares

Full Professor

Universidad Complutense de Madrid

SPAIN
View details

Wim Laleman

MD PhD

-

BELGIUM
View details

Patrizia Burra

Vice Rector for Research Training

University of Padova

ITALY
View details

Nikolaj Christian Torp

University of Southern Denmark

DENMARK
View details

Elisa Pose

University of Barcelona

SPAIN
View details

Roberta Gagliardi

University of Padua

ITALY
View details

Indra Neil Guha

University of Nottingham

UNITED KINGDOM
View details

Giacomo Zaccherini

Tenured Assistant Professor of Internal Medicine

University of Bologna

ITALY
View details